If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
687.00    0.00 (0.00%)
Bid:
680.00
Ask:
694.00
Spread: 14.00 (2.059%)
Market Cap: £242.09m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Director/PDMR Shareholding

27 Mar 2025 07:00

RNS Number : 3918C
B.P. Marsh & Partners PLC
27 March 2025
 

27 March 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh" or the "Company")

Issue of Share Options & Director/PDMR Dealings

 

B.P. Marsh, the specialist investor in early-stage financial services businesses, announces the granting of an aggregate of 490,000 Options over ordinary shares of 10p each in the Company to certain Directors and other employees of the Company.

 

The 490,000 Options were granted following the lapse of 490,000 Options, 400,000 of which had previously been granted to former Persons Discharging Managerial Responsibilities ("PDMR") as announced on 15 November 2023. The total number of Options that have been granted (being 1,685,000) remains unchanged.

 

Certain Directors who are PDMRs have been awarded Options with details of those awards in the disclosure notices below. The remaining Options have been granted to other employees of B.P. Marsh.

 

The Options have been granted under, and will vest in accordance with, the Company's existing Share Option Plan (the "Plan"), as announced on 15 November 2023 and 20 November 2023.

 

The total number of Options granted under the Plan represents approximately 4.35% of the fully diluted shares outstanding.

 

For further information, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

    

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alice Foulk

2

Reason for notification

a)

Position / status

Managing Director (PDMR)

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Grant of Share Options as part of the Share Option Plan

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

10p

90,000

d)

Aggregated information

N/A (single transaction)

e)

Date of the transaction

27/03/25

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Daniel Topping

2

Reason for notification

a)

Position / status

Chief Investment Officer (PDMR)

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Grant of Share Options as part of the Share Option Plan

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

10p

90,000

d)

Aggregated information

N/A (single transaction)

e)

Date of the transaction

27/03/25

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Francesca Chappell

2

Reason for notification

a)

Position / status

Group Finance Director (PDMR)

b)

Initial notification / amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

B.P. Marsh & Partners Plc

b)

LEI

2138008G8EPE3HAHEM13

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0XLRJ79

b)

Nature of the transaction

Grant of Share Options as part of the Share Option Plan

c)

Price(s) and volumes(s)

Price(s)

Volume(s)

10p

62,500

d)

Aggregated information

N/A (single transaction)

e)

Date of the transaction

27/03/25

f)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

Notes to Editors:

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for over ten years. 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBCGDXRDDDGUL
Date   Source Headline
2nd Nov 20173:17 pmRNSDirector/PDMR Shareholding
31st Oct 201712:04 pmRNSDirector/PDMR Shareholding
26th Oct 20174:00 pmRNSInvestee Company Update
24th Oct 20177:02 amRNSDirector/PDMR Shareholding
24th Oct 20177:01 amRNSDirector/PDMR Shareholding
24th Oct 20177:00 amRNSDirector/PDMR Shareholding
19th Oct 20173:55 pmRNSDirector/PDMR Shareholding
17th Oct 20177:00 amRNSInterim Results
16th Oct 20177:00 amRNSInvestment in Mark Edward Partners LLC
7th Sep 20177:00 amRNSTrading Update
6th Sep 20177:00 amRNSDirectorate Change
31st Jul 20176:06 pmRNSDirector/PDMR Shareholding
31st Jul 20176:04 pmRNSDirector/PDMR Shareholding
27th Jul 20177:00 amRNSInvestee Company Update
24th Jul 20173:50 pmRNSShare Buy-Back Policy
19th Jul 20174:24 pmRNSResult of AGM
19th Jul 20179:16 amRNSInvestee Company Update
18th Jul 20172:07 pmRNSInvestee Company Update - Nexus Underwriting
13th Jul 20175:10 pmRNSInvestee Company Update
5th Jul 20173:25 pmRNSDirector/PDMR Shareholding
30th Jun 201710:36 amRNSInvestee Company Update - Nexus Underwriting
29th Jun 20173:26 pmRNSShare Incentive Plan
28th Jun 20173:07 pmRNSNotice of AGM
19th Jun 20173:20 pmRNSInvestment
14th Jun 20173:55 pmRNSDirector/PDMR Shareholding
14th Jun 20172:56 pmRNSDirector/PDMR Shareholding
13th Jun 20171:10 pmRNSInvestment in North America
12th Jun 20174:01 pmRNSDirector/PDMR Shareholding
12th Jun 20173:56 pmRNSDirector/PDMR Shareholding
9th Jun 20177:05 amRNSDirector/PDMR Shareholding
9th Jun 20177:00 amRNSDirector/PDMR Shareholding
6th Jun 20177:00 amRNSFinal Results
25th Apr 20171:17 pmRNSDirector/PDMR Shareholding
24th Apr 20174:40 pmRNSChange of Registered Office
19th Apr 20175:40 pmRNSResult of General Meeting
12th Apr 20174:07 pmRNSBesso Disposal Update
6th Apr 20175:36 pmRNSDirector/PDMR Shareholding
5th Apr 201712:28 pmRNSPDMR Share Sale Plan
3rd Apr 201712:43 pmRNSDisposal and Notice of General Meeting
16th Mar 20174:50 pmRNSTransaction in Own Shares
15th Mar 20175:04 pmRNSShare Buy-Back Policy Update
15th Mar 20175:02 pmRNSDirector/PDMR Shareholding
15th Mar 20172:47 pmRNSTransaction in Own Shares
14th Mar 20172:16 pmRNSTransaction in Own Shares
13th Mar 20173:56 pmRNSTransaction in Own Shares
10th Mar 20176:18 pmRNSTransaction in Own Shares
3rd Mar 20173:23 pmRNSTransaction in Own Shares
3rd Mar 20173:21 pmRNSDirector/PDMR Shareholding
3rd Mar 201711:12 amRNSShare Buy-Back Policy
28th Feb 20174:17 pmRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.